Epirubicin 50 mg Injection Erubin

Trade Name: Erubin

Manufacturer: RPG Life Sciences Ltd

Presentation: Injection

Strength: 50mg

What is Epirubicin 50 mg Injection used for?

Breast cancer patients who have had surgery to remove the tumour are given Epirubicin 50 mg Injection in combination with other cancer treatments. It belongs to a class of drugs known as antineoplastics. It inhibits the growth of cancer cells, causing them to be eliminated.

How is epirubicin given?

Epirubicin is administered through intravenous injection (IV). The syringe needle is inserted directly into the tubing of a freely flowing IV fluid and the medicine is administered over several minutes. A vesicant is epirubicin.

How does epirubicin affect the heart?

It can sometimes weaken the heart’s ability to pump blood. There is a chance that it will cause long-term heart damage in certain people. The study’s major goal was to uncover things that could assist them to figure out who is more at risk of heart damage from epirubicin.

How long does epirubicin stay in the body?

It can take up to 30 minutes if taken alone, but it may take longer if used with other medications. Epirubicin may be given every week for up to 8 weeks to treat bladder cancer.

How effective is epirubicin?

For a total of eight treatment cycles, the patients got single high doses of the medication every three weeks. The overall response rate was 79 percent, with 22 percent of respondents providing complete responses. Low blood counts were the most common side effect. To know click here.

Can you have epirubicin twice?

Epirubicin is administered intravenously (into a vein) by a doctor or nurse in a medical facility, along with other chemotherapy drugs. It can be administered once every 21 days for six cycles of therapy or twice every 28 days (on days 1 and 8) for six cycles of therapy.

We are a Global wholesaler and exporter from India and operate in more than 5 countries like Oman, Qatar, UAE, Saudi, Myanmar.  If you’re looking for a different product or brand, click here.